|
S100PBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2415000000553E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.964800E-04 |
| Normal-vs-Stage2 |
1.435830E-02 |
| Normal-vs-Stage3 |
3.518800E-01 |
| Normal-vs-Stage4 |
6.102000E-01 |
| Stage1-vs-Stage2 |
1.739610E-01 |
| Stage1-vs-Stage3 |
1.294980E-01 |
| Stage1-vs-Stage4 |
3.145600E-01 |
| Stage2-vs-Stage3 |
4.137700E-02 |
| Stage2-vs-Stage4 |
6.571600E-02 |
| Stage3-vs-Stage4 |
9.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67423999999361E-05 |
| Normal-vs-AfricanAmerican |
4.821000E-03 |
| Normal-vs-Asian |
7.279800E-01 |
| Caucasian-vs-AfricanAmerican |
8.738600E-01 |
| Caucasian-vs-Asian |
3.289000E-01 |
| AfricanAmerican-vs-Asian |
3.865600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.55670000000696E-05 |
| Normal-vs-Female |
1.785490E-04 |
| Male-vs-Female |
4.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.022750E-01 |
| Normal-vs-Extreme_Weight |
4.001000E-03 |
| Normal-vs-Obese |
1.436280E-03 |
| Normal-vs-Extreme_Obese |
1.100590E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.998800E-01 |
| Normal_Weight-vs-Obese |
1.285770E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.257600E-01 |
| Extreme_Weight-vs-Obese |
4.082000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.894400E-01 |
| Obese-vs-Extreme_Obese |
8.676600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.369600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.77720000055426E-07 |
| Normal-vs-Age(61-80Yrs) |
1.198220E-03 |
| Normal-vs-Age(81-100Yrs) |
6.824600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.769800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.227800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.137830E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.432580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.049910E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.253810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40679999871551E-08 |
| Normal-VS-Type2 PRCC |
9.053800E-01 |
| Normal-VS-KIRP CIMP |
1.042790E-01 |
| Normal-VS-Unclassified PRCC |
4.700200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.67860000011011E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.789600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.371200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.457800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.904900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.423000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.647900E-02 |
| Normal-vs-N1 |
1.556550E-01 |
| Normal-vs-N2 |
4.843200E-01 |
| N0-vs-N1 |
5.397400E-01 |
| N0-vs-N2 |
7.815200E-01 |
| N1-vs-N2 |
7.098600E-01 |
|
|
